Proton-therapy and concurrent chemotherapy in stage III NSCLC: effects on hematological toxicity

被引:0
|
作者
Cortiula, F. [1 ]
Hendriks, L. [2 ]
Steens, M. [3 ]
Dursun, S. [2 ]
Bootsma, G. [3 ]
Canters, R. [1 ]
Rinaldi, I. [1 ]
Taasti, V. T. [1 ]
Houben, R. [1 ]
Reynders, K. [1 ]
Peeters, S. [1 ]
Angrisani, A. [1 ]
Hattu, D. [1 ]
De Ruysscher, D. [1 ]
机构
[1] Maastricht Univ Med Ctr, Dept Radiat Oncol MAASTRO, Maastricht, Netherlands
[2] Maastricht Univ Med Ctr, Dept Pulm Dis, Maastricht, Netherlands
[3] Zuyderland Med Ctr, Dept Pulm Dis, Geleen, Netherlands
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
OC-0438
引用
收藏
页码:S381 / S382
页数:2
相关论文
共 50 条
  • [1] Proton-therapy and concurrent chemotherapy in stage III NSCLC: Effects on toxicity and immune therapy
    Cortiula, F.
    Hendriks, L.
    Wijsman, R.
    Debakker, S.
    Steens, M.
    Peeters, S. T.
    Michelotti, A.
    Sijtsema, N. M.
    Urban, S.
    Niezink, A.
    Dursun, S.
    Bootsma, G.
    Canters, R.
    Tohidinezhad, F.
    Fasola, G.
    Rinaldi, I.
    Taasti, V.
    Houben, R.
    De Ruysscher, D.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S984 - S985
  • [2] Proton-therapy and concurrent chemotherapy in stage III NSCLC: Effects on durvalumab eligibility and safety profile
    Cortiula, F.
    De Ruysscher, D.
    Dursun, S.
    Steens, M.
    Bootsma, G.
    Canters, R.
    Rinaldi, I.
    Taasti, V. T.
    Houben, R.
    Reynders, K.
    Peeters, S.
    Angrisani, A.
    Hattu, D.
    Hendriks, L.
    ANNALS OF ONCOLOGY, 2022, 33 : S85 - S85
  • [3] Chemotherapy with concurrent proton vs. photon radiotherapy in stage III NSCLC: Effects on hematological toxicity and immune therapy
    Cortiula, F.
    Hendriks, L.
    Wijsman, R.
    Houben, R.
    Steens, M.
    Debakker, S.
    Reverberi, C.
    Sijtsema, N. M.
    Niezink, A.
    Urban, S.
    Michelotti, A.
    Dursun, S.
    Bootsma, G.
    Hattu, D.
    Canters, R.
    Moretti, E.
    Taasti, V. T.
    De Ruysscher, D.
    ANNALS OF ONCOLOGY, 2023, 34 : S748 - S749
  • [4] Proton and photon radiotherapy in stage III NSCLC: Effects on hematological toxicity and adjuvant immune therapy
    Cortiula, Francesco
    Hendriks, Lizza E. L.
    Wijsman, Robin
    Houben, Ruud
    Steens, Michelle
    Debakker, Sarah
    Canters, Richard
    Trovo, Marco
    Sijtsema, Nanna M.
    Niezink, Anne G. H.
    Unipan, Mirko
    Urban, Susanna
    Michelotti, Anna
    Dursun, Safiye
    Bootsma, Gerben
    Hattu, Djoya
    Nuyttens, Joost J.
    Moretti, Eugenia
    Taasti, Vicki T.
    De Ruysscher, Dirk
    RADIOTHERAPY AND ONCOLOGY, 2024, 190
  • [5] Concurrent chemotherapy and proton beam therapy in NSCLC
    Das, Manjulika
    LANCET ONCOLOGY, 2017, 18 (09): : E515 - E515
  • [6] UF-Pcg Phase II Study of Hypofractionated Proton Therapy with Concurrent Chemotherapy for Stage II-III NSCLC
    Hoppe, B. S.
    Nichols, R. C., Jr.
    Pham, D. C.
    Mohindra, P.
    Hartsell, W. F.
    Mohammed, N.
    Chon, B. H.
    Morris, C. G.
    Li, Z.
    Flampouri, S.
    Simone, C. B., II
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S144 - S144
  • [7] Failure Patterns and Toxicity of Concurrent Proton Therapy and Chemotherapy for Stage III Non-small Cell Lung Cancer
    Chang, J. Y.
    Komaki, R.
    Bucci, M. K.
    Lu, C.
    Wen, H. Y.
    DeGracia, B.
    Gillin, M.
    Mohan, R.
    Cox, J. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S446 - S447
  • [8] SOCCAR: Sequential or concurrent chemotherapy and hypofractionated accelerated radiotherapy in inoperable stage III NSCLC
    Maguire, J.
    McMenemin, R.
    O'Rourke, N.
    Peedell, C.
    Snee, M.
    Mcnee, S.
    Kelly, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [9] SOCCAR: SEQUENTIAL OR CONCURRENT CHEMOTHERAPY AND HYPOFRACTIONATED ACCELERATED RADIOTHERAPY IN INOPERABLE STAGE III NSCLC
    Maguire, Joe
    O'Rourke, Noelle
    Peedell, Clive
    Mcmenemin, Rhona
    Snee, Michael P.
    Mcnee, Stuart
    Kelly, Veronica
    Khan, Iftekhar
    Slade, Rachel
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1561 - S1562
  • [10] High-dose concurrent chemo-proton therapy for Stage III NSCLC: preliminary results of a Phase II study
    Oshiro, Yoshiko
    Okumura, Toshiyuki
    Kurishima, Koichi
    Homma, Shinsuke
    Mizumoto, Masashi
    Ishikawa, Hitoshi
    Onizuka, Masataka
    Sakai, Mitsuaki
    Goto, Yukinobu
    Hizawa, Nobuyuki
    Sato, Yukio
    Sakurai, Hideyuki
    JOURNAL OF RADIATION RESEARCH, 2014, 55 (05) : 959 - 965